22-45289121-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006953.4(UPK3A):​c.549A>G​(p.Ser183Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.463 in 1,613,364 control chromosomes in the GnomAD database, including 181,954 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 26658 hom., cov: 31)
Exomes 𝑓: 0.45 ( 155296 hom. )

Consequence

UPK3A
NM_006953.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -6.86

Publications

22 publications found
Variant links:
Genes affected
UPK3A (HGNC:12580): (uroplakin 3A) This gene encodes a member of the uroplakin family, a group of transmembrane proteins that form complexes on the apical surface of the bladder epithelium. Mutations in this gene may be associated with renal adysplasia. Alternatively spliced transcript variants have been described.[provided by RefSeq, Nov 2009]
UPK3A Gene-Disease associations (from GenCC):
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal dysplasia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • congenital anomaly of kidney and urinary tract
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 22-45289121-A-G is Benign according to our data. Variant chr22-45289121-A-G is described in ClinVar as Benign. ClinVar VariationId is 341981.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.86 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.835 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UPK3ANM_006953.4 linkc.549A>G p.Ser183Ser synonymous_variant Exon 4 of 6 ENST00000216211.9 NP_008884.1 O75631-1
UPK3ANM_001167574.2 linkc.208+3025A>G intron_variant Intron 2 of 3 NP_001161046.1 O75631-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UPK3AENST00000216211.9 linkc.549A>G p.Ser183Ser synonymous_variant Exon 4 of 6 1 NM_006953.4 ENSP00000216211.4 O75631-1
UPK3AENST00000396082.2 linkc.208+3025A>G intron_variant Intron 2 of 3 1 ENSP00000379391.2 O75631-2

Frequencies

GnomAD3 genomes
AF:
0.562
AC:
85353
AN:
151894
Hom.:
26594
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.842
Gnomad AMI
AF:
0.393
Gnomad AMR
AF:
0.511
Gnomad ASJ
AF:
0.405
Gnomad EAS
AF:
0.688
Gnomad SAS
AF:
0.577
Gnomad FIN
AF:
0.466
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.419
Gnomad OTH
AF:
0.525
GnomAD2 exomes
AF:
0.499
AC:
125270
AN:
250872
AF XY:
0.494
show subpopulations
Gnomad AFR exome
AF:
0.847
Gnomad AMR exome
AF:
0.494
Gnomad ASJ exome
AF:
0.411
Gnomad EAS exome
AF:
0.698
Gnomad FIN exome
AF:
0.465
Gnomad NFE exome
AF:
0.418
Gnomad OTH exome
AF:
0.470
GnomAD4 exome
AF:
0.453
AC:
661583
AN:
1461352
Hom.:
155296
Cov.:
49
AF XY:
0.454
AC XY:
329709
AN XY:
726968
show subpopulations
African (AFR)
AF:
0.856
AC:
28668
AN:
33480
American (AMR)
AF:
0.498
AC:
22279
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.412
AC:
10767
AN:
26132
East Asian (EAS)
AF:
0.671
AC:
26640
AN:
39692
South Asian (SAS)
AF:
0.555
AC:
47903
AN:
86252
European-Finnish (FIN)
AF:
0.458
AC:
24361
AN:
53162
Middle Eastern (MID)
AF:
0.492
AC:
2836
AN:
5768
European-Non Finnish (NFE)
AF:
0.422
AC:
468831
AN:
1111766
Other (OTH)
AF:
0.485
AC:
29298
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
18193
36386
54579
72772
90965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14734
29468
44202
58936
73670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.562
AC:
85489
AN:
152012
Hom.:
26658
Cov.:
31
AF XY:
0.565
AC XY:
41980
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.842
AC:
34929
AN:
41466
American (AMR)
AF:
0.511
AC:
7807
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.405
AC:
1404
AN:
3464
East Asian (EAS)
AF:
0.689
AC:
3549
AN:
5154
South Asian (SAS)
AF:
0.577
AC:
2779
AN:
4816
European-Finnish (FIN)
AF:
0.466
AC:
4928
AN:
10572
Middle Eastern (MID)
AF:
0.565
AC:
166
AN:
294
European-Non Finnish (NFE)
AF:
0.419
AC:
28455
AN:
67958
Other (OTH)
AF:
0.530
AC:
1115
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1702
3404
5107
6809
8511
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.452
Hom.:
34453
Bravo
AF:
0.576
Asia WGS
AF:
0.678
AC:
2354
AN:
3478
EpiCase
AF:
0.415
EpiControl
AF:
0.422

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Renal hypodysplasia/aplasia 1 Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Oct 10, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.027
DANN
Benign
0.43
PhyloP100
-6.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1135360; hg19: chr22-45685002; COSMIC: COSV53414471; API